{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:51:20Z","timestamp":1787946680103,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1006\/clin.1997.4483","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T18:27:27Z","timestamp":1033928847000},"page":"298-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["IL-10 Production in Common Variable Immunodeficiency"],"prefix":"10.1006","volume":"86","author":[{"given":"Zhuo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Danon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4483_II974483RF1","first-page":"1","volume":"109","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197407042910101","article-title":"Heterogeneity of \u201cacquired\u201d or common variable agammaglobulinemia","volume":"291","author":"Geha","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF00917124","article-title":"Clinical and immunologic analysis of 103 patients with common variable immunodeficiency","volume":"9","author":"Cunningham-Rundles","year":"1989","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF4","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1073\/pnas.79.19.6008","article-title":"Three distinct stages of B cell defects in common varied immunodeficiency","volume":"79","author":"Saiki","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4483_II974483RF5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI110305","article-title":"Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders","volume":"68","author":"Reinherz","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4483_II974483RF6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00915478","article-title":"Impaired proliferative response to B lymphocyte activators in common variable immunodeficiency","volume":"1","author":"Cunningham-Rundles","year":"1981","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00915297","article-title":"Interleukin-2 correction of defectivein vitroT cell mitogenesis in patients with common varied immunodeficiency","volume":"4","author":"Kruger","year":"1984","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.128.2.679","article-title":"Relationship between IL-2 synthesis and proliferative response to PHA in different primary immunodeficiencies","volume":"128","author":"Lopez-Botet","year":"1982","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0167-5699(89)90323-X","article-title":"The role of lymphokines in common variable hypogammaglobulinemia","volume":"10","author":"Spickett","year":"1989","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4483_II974483RF10","first-page":"334","article-title":"Peripheral blood lymphocytes of patients with common variable immunodeficiency produce reduced levels of IL-4, IL-2, interferon gamma, but proliferative normally upon activation by mitogens","volume":"78","author":"Pastorelli","year":"1989","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF11","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.144.10.3762","article-title":"Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency","volume":"144","author":"Sneller","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF12","doi-asserted-by":"crossref","first-page":"21150","DOI":"10.1172\/JCI111636","article-title":"Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors","volume":"74","author":"Mayer","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4483_II974483RF13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0091-6749(93)90178-I","article-title":"Defective interleukin-2 and inteferon gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency","volume":"92","author":"Fischer","year":"1993","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2249.1997.tb08313.x","article-title":"A double blind, placebo controlled, crossover therapy study with natural human IL-2 (nhu IL-2) in combination with regular intravenous immunoglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID)","volume":"110","author":"Rump","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0090-1229(88)90117-1","article-title":"In vitroinduction of T cell dependent B cell differentiation in patients with common varied immunodeficiency","volume":"49","author":"Stohl","year":"1987","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1997.4483_II974483RF16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0090-1229(92)90058-V","article-title":"Restoration of immunoglobulin secretionin vitroin common variable immunodeficiency byin vivotreatment with polyethylene glycol conjugated human recombinant interleukin-2","volume":"64","author":"Cunningham-Rundles","year":"1992","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1997.4483_II974483RF17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJM199410063311405","article-title":"Enhanced humoral immunity in common variable immunodeficiency after long term treatment with polyethylene glycol-conjugated interleukin-2","volume":"331","author":"Cunningham-Rundles","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","article-title":"IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF19","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/intimm\/2.9.821","article-title":"Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10","volume":"2","author":"O'Garra","year":"1990","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/eji.1830220314","article-title":"Lyl B (B-1) cells are the main source of B-cell derived IL-10","volume":"22","author":"O'Garra","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF22","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.149.7.2378","article-title":"IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells","volume":"149","author":"Yssel","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF23","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"IL-10 and viral IL-10 strongly reduce antigen specific human T cell responses by diminishing the antigen presenting capacity of monocytes via down-regulation of class II MHC expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF25","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Human and viral Interleukin 10 are potent growth and differentiation factors for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clin.1997.4483_II974483RF26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.179.2.757","article-title":"Human interleukin 10 induces naive surface immunoglobulin D+ (slgD+) B cells to secrete IgG1 and IgG3","volume":"179","author":"Briere","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4483_II974483RF27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1172\/JCI116701","article-title":"Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin","volume":"92","author":"Nonoyama","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1997.4483_II974483RF28","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.4049\/jimmunol.152.12.5957","article-title":"B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10","volume":"152","author":"Eisenstein","year":"1994","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0140-6736(93)91746-9","article-title":"Interleukin 10 and immune restoration in common variable immunodeficiency","volume":"342","author":"Zielen","year":"1993","journal-title":"Lancet"},{"key":"10.1006\/clin.1997.4483_II974483RF30","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.4049\/jimmunol.142.7.2343","article-title":"Characteristics of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody stimulated T cells","volume":"142","author":"Sherris","year":"1989","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4049\/jimmunol.120.6.2027","article-title":"T cell growth factor: Parameters of production and a quantitative increase for activity","volume":"120","author":"Gillis","year":"1978","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1126\/science.3726549","article-title":"A macrophage derived factor required by plasmocytomas for survival and proliferationin vitro","volume":"233","author":"Nordan","year":"1986","journal-title":"Science"},{"key":"10.1006\/clin.1997.4483_II974483RF33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1992.tb01406.x","article-title":"Strategies of anti-cytokine monoclonal antibody development: Immunoassays of IL-5 and IL-10 in clinical samples","volume":"127","author":"Abrams","year":"1992","journal-title":"Immunol. Rev."},{"key":"10.1006\/clin.1997.4483_II974483RF34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0090-1229(87)90066-3","article-title":"T cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages","volume":"44","author":"Fieldler","year":"1987","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1997.4483_II974483RF35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4049\/jimmunol.148.4.1143","article-title":"IL-10 inhibits human T cell proliferation and IL-2 production","volume":"148","author":"Taga","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF36","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.4049\/jimmunol.150.11.4754","article-title":"Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells","volume":"150","author":"de Waal Malefyt","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF37","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.4049\/jimmunol.154.10.5492","article-title":"A randomized, controlled trial of IL-10 in humans","volume":"154","author":"Chernoff","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.132.2.745","article-title":"Modulation of mononuclear phagocyte function by IV gammaglobulin","volume":"132","author":"Kimberly","year":"1984","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00920238","article-title":"Intravenous immunoglobulin induces interferon-\u03b3 and interleukin-6in vivo","volume":"13","author":"Ling","year":"1993","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V82.7.2169.2169","article-title":"Serum interleukin 10 in non-Hodgkin's lymphoma: A prognostic factor","volume":"82","author":"Blay","year":"1993","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4483_II974483RF41","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(92)92795-H","article-title":"Elevated interleukin-10 (IL-10) in the plasma of patients with early stage multiple myeloma","volume":"340","author":"Merville","year":"1992","journal-title":"Lancet"},{"key":"10.1006\/clin.1997.4483_II974483RF42","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2249.1994.tb06527.x","article-title":"High levels of circulating IL-10 in human malaria","volume":"95","author":"Peyron","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4483_II974483RF43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997944834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:09:09Z","timestamp":1758762549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997944834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["S0090122997944834"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4483","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1998,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-10 Production in Common Variable Immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}